Strong Regulation of Medical Products: Cornerstone of Public Health and Regional Health Security

Susann Roth, Douglas Ball, Jane Parry, Sonalini Khetrapal and Valerio Reggi

Working Papers from eSocialSciences

Abstract: National regulatory agencies (NRAs) are the gatekeepers of the supply chain of medical products such as pharmaceuticals and medical devices. It is through registration with an NRA that a manufacturer brings products to market. Postmarketing surveillance of how those products perform and impact patient safety— including how quality is maintained in storage and distribution, and adverse events associated with their use—also falls under the agency’s remit, as does inspection of manufacturing facilities and regulation of product promotion and advertising. At the same time, the value chain for medical products is becoming increasingly globalized. In pharmaceutical manufacturing, for example, active ingredients may be sourced from multiple countries for medicines production in another, before being globally distributed. A weakness in one part of the supply chain can have adverse consequences for patients thousands of miles away.

Keywords: eSS; National regulatory agencies (NRAs); supply chains; medical products; pharmaceuticals; medical devices; regsitration; market; post-marketing surveillance; storage; distribution; promotion. (search for similar items in EconPapers)
Date: 2018-10
Note: Institutional Papers
References: Add references at CitEc
Citations:

Downloads: (external link)
http://www.esocialsciences.org/Download/repecDownl ... AId=12936&fref=repec

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:ess:wpaper:id:12936

Access Statistics for this paper

More papers in Working Papers from eSocialSciences
Bibliographic data for series maintained by Padma Prakash ().